Marco de Boer contributes his experience in the development and marketing of Predica’s products. Marco has held several management positions: CEO at NTrans Technologies BV, COO at Crossbeta Biosciences BV, Head of Research at to-BBB, Head of Bioprocessing at Kerry I&F, Director Biomolecules at Isogen Life Science, and Research Manager at Unilever Research, Vlaardingen. Marco received an MBA from the Nyenrode Business University.

Dr. William Leenders is the inventor of the ciRNAseq technology. He has a strong background in chemistry, biochemistry, molecular biology and cell biology, and is active as a cancer researcher in the Radboudumc for more than 25 years. He is an associate professor and staff member of the Radboudumc department of Biochemistry.

Hans van Leeuwen has ample expertise supporting Predica’s mission, having held research positions in multiple disciplines including analytical chemistry, statistics and data analysis and information technology/artificial intelligence. He has held management positions in statistics, R&D IT and regulatory affairs in chemical and pharmaceutical industry. Hans holds a Ph.D. in Chemistry from Radboud University Nijmegen.

Menno Rasing obtained his MSc degree in Biotechnology at the Wageningen University. He is a dedicated research technician with great hands-on laboratory experience in Molecular Biology. With his proficiency in experimental techniques and increasing knowledge about quality standards, he is contributing to the design and development of Predica’s ciRNAseq-based products.

Bernard Pater graduated from the Radboud University with a Master of Science in the field of Medical epigenomics. He is an expert on NGS and third generation sequencing technology, as well as the data analysis required for working with modern sequencing technologies.

Anna Berghuis obtained her Master of Science degree at Radboud University Nijmegen. She is a researcher with laboratory experience. With her specific knowledge of gynaecology and gynaecological oncology, she maintains relations with clinicians and ensures that the product development activities meet the medical, business, and regulatory needs.